* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Approach to Poisonings
Neuropharmacology wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Pharmacognosy wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Prescription costs wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
Drug interaction wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Theralizumab wikipedia , lookup
Approach to Poisonings Robert J. Vinci, MD Background • 2 – 5 Million exposures per year • 4% require hospitalization • 96% minor or no effects Background • • • • • • 93% involve a single substance 67 % patients < 20 years of age 53% children < 6 years of age 25% children < 2 years of age Bimodal Pediatric age distribution Household products vs. pharmaceuticals Fatalities • • • • • • • Cleaning substances Analgesics Antidepressants Heavy metals, especially iron Street drugs Cardiovascular drugs Alcohols How do Children Present? • Vague History • Change in mental status • Suspicion of Ingestion – Open bottles – Pills on floor – Missing medications • Directly Observed Initial Evaluation • History – When – How Much – Symptoms – Meds in the Home – Any other possible exposures – Observations from EMS personnel Initial Evaluation • History – Seizures – GI symptoms – Hallucinations – Toxidromes Initial Evaluation • Physical Examination – ABC’s – Rapid deterioration – Review vital signs for clues – Mental Status – Pupils – Nystagmus – Skin Color/Skin Warmth Initial Evaluation • Laboratory Studies – Pulse Oximetry – EKG – Electrolytes/Blood Sugar – ABG’s – Toxic Screen/Drug Levels – Serum osmolality/osmolal gap Increased Anion Gap Acidosis • • • • • Methanol Ethylene Glycol Salicylates Iron, INH, Ibuprofen Drugs producing hypotension and lactic acidosis (many serious ingestions) Increased Osmolal Gap • Osmolal Gap = Osm (calc) – Osm (meas.) • Osmolal Calc. = 2 x Na + Gluc + BUN 18 2.6 • Increased Osmolal Gap – – – – Ethanol Methanol Ethylene Glycol Acetone Radiographic Studies • • • • • • • CHIPES C= Chloral Hydrate H= Heavy Metals, especially Iron I= Iodinated compounds (thyroxin) P= Psychotropic, Packers E= Enteric Coated Medications S= Salicylates, Sustained Release Toxidromes • Hyperthermia, agitation, mydriasis, hypertensive hyperthermic • Coma, Seizures, arrhythmia • Coma, respiratory depression, myosis • Hallucinations, mydriasis, hot dry skin, urinary retention, tachycardia • Sympathomimetics • Tricyclics • Opiods • Anticholinergics Serum Toxic Screens • • • • Aspirin Salicylates Alcohols Tricyclics Urine Toxic Screens • • • • • Benzodiazepines Barbiturates Opiates PCP Marijuana General Management • • • • Supportive Care Oxygen Intravenous glucose Careful monitoring for potential side effects Specific Management • • • • Gastric Emptying Decrease Absorption Enhance Elimination Specific Antidotes Gastric Emptying • Syrup of Ipecac – Stimulates Gastric Receptors linked to the CNS vomiting center – Emesis within 20 minutes – 80% after a single dose – 99% after two doses – Vomiting persists for 1 – 2 hours and may delay use of oral antidotes and treatments Syrup of Ipecac Should it be Used? • Adverse Effects – Uncontrolled vomiting/ Mallory Weiss Tear – Sedation – Fatal aspiration • 30% recovered < one hour of ingestion. Minimal toxin recovered after 90 minutes • No true evidence it improves outcome • Not studied well with delayed gastric emptying or decreased peristalsis When to Consider Ipecac • Alert, conscious children > 6 months of age • Ingestion of potentially toxic amount of poisoning • Within 60 minutes of ingestion • Perhaps at home or in pre-hospital setting • Limited value in the hospital setting Syrup of Ipecac Contraindications to Use • Substance that produces rapid change in mental status • Calcium channel blocker, digitalis, betablocker (worsen bradycardia of vomiting) • Corrosives • Mental Status changes/Decreased Gag • Coagulopathy • Infants less than 6 months of age Ipecac Adverse Effects • Protracted vomiting, sedation or diarrhea • Forceful vomiting (Mallory-Weiss tears, pneumomediastinum, bradycardia) • Sedation or seizures leading to aspiration • Cardiomyopathy with chronic abuse • May delay oral therapy, especially charcoal Gastric Lavage • Need Presence of gag – now and during the procedure • Left Lateral Decubitus/Trendenburg • Large Bore Single Lumen tube • After confirming position of tube, 10 – 15 ml/kg aliquots of saline until clear • Removes < 30 % of what is ingested (similar to ipecac) • Similar contraindications to ipecac Gastric Lavage Contraindications • Corrosives • Uncooperative child • History of GI surgery/pathology Gastric Lavage Technique • Confirm presence of gag reflex • Left lateral decubitus position with head lower than feet • Largest possible tube • Lavage with aliquots of 10 ml/kg until clear Charcoal - Adsorbent • Binding surface areas of 3000 m2/gm • Maintains attachment through covalent bonding • If treatment occurs within one hour as much as 75% of toxin is adsorbed • Dose is 10:1 ratio, however a fixed dose of 1 gram/kg is recommended • May mix with flavoring to hide taste • ?Use with NG tube???? Use of Charcoal • 1 gm/kg of body weight • Often pre-mixed as aqueous solution or with a cathartic such as sorbitol • May flavor with cola, chocolate syrup in order to make it more palatable • More effective than ipecac or gastric lavage • Greatest benefit if used within one hour of ingestion Charcoal “Contraindications” • • • • • • Hydrocarbons Alcohols Heavy Metals (Iron) Minerals Corrosives (makes endoscopy difficult) GI perforation Multiple Dose Activated Charcoal • Drugs which decrease gastrointestinal mobility • Enterohepatic circulation • Gastric Dialysis • Give 0.5 mg/kg of charcoal without sorbitol every 4 – 6 hours Adverse Effects of Charcoal • Aspiration • Diarrhea, if used with sorbitol • Fluid loss and electrolyte abnormality Cathartics • Osmotic Agents used to treat ingestions • Increase Gastric Motility • In pediatric patients the use of cathartics should be limited to the first dose of charcoal Magnesium Citrate • 4 ml/kg of 6% suspension • Larger doses do not improve efficacy • Magnesium does get absorbed Sorbitol • • • • The most efficient osmotic agent 1 – 2 grams/kg Not recommended in children < 1 year May cause hypernatremic dehydration and cardiovascular collapse Whole-Bowel Irrigation • Polyethylene glycol-electrolyte solution • There is no absorption • Large volumes infused (500 – 1000 ml per hour) until effluent is clear • Treatment of choice for agents which are not well absorbed by charcoal Indications • • • • • Enteric coated pills Sustained release tablets Illicit drug packets Drug concretions Ingestions of substances poorly bound by charcoal Common Antidotes • • • • • • • • Opiate Overdose Acetominophen Salicylates Digoxin Iron INH Ethylene Glycol Tricyclics • • • • • • • • Narcan N-acetylcysteine Alkalinization Fab Antibodies Deferoxamine Pyridoxine Fomepazole Sodium Bicarbonate Approach to Patients • Avoid the use of ipecac • Gastric lavage has not been shown to be effective • In general, activated charcoal is the sole intervention necessary to treat serious poisonings. This may be used with or without a cathartic Poison Control Centers • 1-800-222-1222 • 617-232-2120 • May be helpful in identification of toxins based on symptoms alone